Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

Oncotarget. 2022 Apr 1:13:583-584. doi: 10.18632/oncotarget.28109. eCollection 2022.

Authors

Sixian Liang^{1

2}, Xun Peng^{3

2}, Xiaoli Li¹, Ping Yang¹, Linhao Xie¹, Yaochen Li⁴, Caiwen Du¹, Guojun Zhang⁴

Affiliations

¹ Department of Breast Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515031, PR China.
² These authors have contributed equally to this work.
³ Department of Radiotherapy, Cancer Hospital of Shantou University Medical College, Shantou 515031, PR China.
⁴ The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou 515031, PR China.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.2741.].

Copyright: © 2022 Liang et al.

Publication types

Published Erratum